Michele Tana, MD, MHS

Associate Clinical Professor
Principal Investigator
Department of Medicine
+1 628 206-4095

Michele Tana grew up in Northern Virginia, studied the Classics at Harvard College, and attended Harvard Medical School. She trained in Internal Medicine at Stanford University Hospital and Clinics and Gastroenterology at California Pacific Medical Center. She was a Hepatology Fellow at the National Institutes of Health in the National Institute of Diabetes and Digestive and Kidney Diseases and earned a Masters Degree in Clinical Research from Duke University.
Dr. Tana joined the UCSF faculty in 2013. She serves the vulnerable patient population at Zuckerberg San Francisco General Hospital and teaches UCSF students and trainees. She directs the Gastroenterology Rotation for Surgery Residents and serves as a Hepatitis C Consultant for the National Clinician Consultation Center. In 2018, she helped launch Prospective Observational Study to Understand Liver Diseases (POSULD). Her team collaborates with researchers across disciplines and across the globe to apply state-of-the-art science and technology to liver diseases, with a focus on health equity in autoimmune hepatitis.

Publications: 

Utility and impact of magnetic resonance elastography in the clinical course and management of chronic liver disease.

Scientific reports

Feuille C, Kari S, Patel R, Oberoi R, Liu J, Ohliger M, Khalili M, Tana M

Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.

medRxiv : the preprint server for health sciences

Klepper A, Kung A, Vazquez SE, Mitchell A, Mann S, Zorn K, Avila-Vargas I, Kari S, Tekeste M, Castro J, Lee B, Duarte M, Khalili M, Yang M, Wolters P, Price J, Perito E, Feng S, Maher JJ, Lai J, Weiler-Normann C, Lohse AW, DeRisi J, Tana M

Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals.

JAMA network open

Yilma M, Kim NJ, Shui AM, Tana M, Landis C, Chen A, Bangaru S, Mehta N, Zhou K

Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis.

The American journal of gastroenterology

Hercun J, Noureddin M, Noureddin N, Eccleston J, Woolridge D, Liang TJ, Tana M, Kleiner DE, Rodriguez GV, Koh C, Hoofnagle JH, Heller T

Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.

PloS one

Tana MM, Klepper A, Lyden A, Pisco AO, Phelps M, McGee B, Green K, Feng S, DeRisi J, Crawford ED, Lammert CS

Outcomes of Pregnancy in Autoimmune Hepatitis: A Population-Based Study.

Hepatology (Baltimore, Md.)

Wang CW, Grab J, Tana MM, Irani RA, Sarkar M

Asian American/Pacific Islander and Hispanic Ethnic Enclaves, Neighborhood Socioeconomic Status, and Hepatocellular Carcinoma Incidence in California: An Update.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Sangaramoorthy M, Yang J, Guan A, DeRouen MC, Tana MM, Somsouk M, Thompson CA, Gibbons J, Ho C, Chu JN, Cheng I, Gomez SL, Shariff-Marco S

Thinking Ahead: Advance Care Planning for Patients With Cirrhosis.

Clinical liver disease

Deng LX, Tana MM, Lai JC

We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases.

Hepatology (Baltimore, Md.)

Lee BT, Tana MM, Kahn JA, Dara L

Prospective Study of Withdrawal of Antiviral therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response.

Hepatology communications

Gara N, Tana MM, Kattapuram M, Auh S, Sullivan L, Fryzek N, Walter M, Umarova R, Zhao X, Cloherty G, Doo E, Heller T, Liang TJ, Ghany MG

Obesity and metabolic outcomes in a safety-net health system.

Biodemography and social biology

Huynh MP, Bradshaw PT, Tana MM, Rachocki C, Somsouk M

Disparities in Hepatocellular Carcinoma Incidence in California: An Update.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Sangaramoorthy M, Yang J, DeRouen MC, Ho C, Somsouk M, Tana MM, Thompson CA, Gibbons J, Gomez SL, Shariff-Marco S

The Spectrum of Hepatic Involvement in Patients With Telomere Disease.

Hepatology (Baltimore, Md.)

Kapuria D, Ben-Yakov G, Ortolano R, Cho MH, Kalchiem-Dekel O, Takyar V, Lingala S, Gara N, Tana M, Kim YJ, Kleiner DE, Young NS, Townsley DM, Koh C, Heller T

Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved.

Autoimmunity

Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM

Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans.

The American journal of gastroenterology

Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM

Imaging Manifestations of Peptic Ulcer Disease on Computed Tomography.

Seminars in ultrasound, CT, and MR

Baghdanian AH, Baghdanian AA, Puppala S, Tana M, Ohliger MA

Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms

Fatigue: Biomedicine, Health & Behavior.

Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y

Fatigued Patients with Chronic Liver Disease Have Subtle Aberrations of Sleep, Melatonin and Cortisol Circadian Rhythms.

Fatigue : biomedicine, health & behavior

Tana MM, Alao H, Morris N, Bernstein S, Hattenbach J, Rehman RB, Brychta R, Sarkar S, Zhao X, Walter M, Buckley A, Chen K, Rotman Y

Diagnosing Liver Fibrosis and Cirrhosis: Serum, Imaging, or Tissue?

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Tana MM, Muir AJ

A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase.

Clinica chimica acta; international journal of clinical chemistry

van Wijk XMR, Magee CA, Wu AHB, Tana MM, Lynch KL

Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.

Journal of clinical gastroenterology

Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis.

American journal of clinical pathology

Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH

Factors associated with the platelet count in patients with chronic hepatitis C.

Thrombosis research

Tana MM, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T

Autoantibodies in hepatitis C: red flag or bystander effect?

Journal of pediatric gastroenterology and nutrition

Tana MM, Heller T

Scar undone: long-term therapy of hepatitis B.

Lancet (London, England)

Tana MM, Hoofnagle JH